VET trades 8.0% above Wall Street's consensus target of $10.74.
Last 12 months price action with 12-month analyst target path
The base valuation assumes VET achieves its forward estimates and maintains a stable P/E multiple of 24.7x. This scenario reflects the blended consensus of 10 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of October 3, 2026, Vermilion Energy Inc. (VET) has a Wall Street consensus price target of $10.74, based on estimates from 10 covering analysts. With the stock currently trading at $11.68, this represents a potential downside of -8.0%. The company has a market capitalization of $1.78B.
Analyst price targets range from a low of $10.74 to a high of $10.74, representing a 0% spread in expectations. The median target of $10.74 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 3 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 3 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, VET trades at a trailing P/E of -3.9x and forward P/E of 24.7x. Analysts expect EPS to grow +116.6% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 BTEBaytex Energy Corp. | $3.3B | $4.63 | — | — | Buy | 11.8x | 16 |
 CVECenovus Energy Inc. | $59.8B | $32.40 | $36.00 | +11.1% | Hold | 7.0x | 27 |
 MEGMontrose Environmental Group, Inc. | $566M | $15.64 | $49.33 | +215.4% | Buy | — | 12 |
 PBAPembina Pipeline Corporation | $26.7B | $45.89 | $68.00 | +48.2% | Buy | 14.9x | 16 |
 OVVOvintiv Inc. | $16.7B | $60.34 | $75.45 | +25.0% | Buy | 8.0x | 27 |
 ARXAccelerant Holdings | $4.3B | $19.73 | $17.75 | -10.0% | Buy | 22.1x | 10 |
 CNQCanadian Natural Resources Limited | $101.0B | $48.44 | $50.81 | +4.9% | Buy | 11.3x | 37 |
 SUSuncor Energy Inc. | $82.1B | $69.56 | $89.00 | +27.9% | Buy | 7.0x | 31 |
 HALHalliburton Company | $26.6B | $31.85 | $43.11 | +35.4% | Buy | 13.6x | 64 |
 SLBSlb N.V. | $72.9B | $48.74 | $64.58 | +32.5% | Buy | 19.7x | 66 |
Quick answers to the most common questions about buying VET stock.
Wall Street's consensus price target for VET is $10.74, -8.0% from its current price of $11.68. The below-market target from 10 analysts suggests limited near-term appreciation.
VET has a consensus rating of "Hold" based on 10 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $10.74 implies -8.0% downside from current levels.
VET trades at a forward P/E of 24.6518x, representing a moderate valuation. With analysts targeting $10.74 (-8.0% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $10.7426 for VET, while the most conservative target is $10.7426. The consensus of $10.74 represents the median expectation. These targets typically reflect 12-month expectations.
VET is moderately covered, with 10 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 4 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month VET stock forecast based on 10 Wall Street analysts shows a consensus price target of $10.74, with estimates ranging from $10.7426 (bear case) to $10.7426 (bull case). The median consensus rating is "Hold".
VET trades at a forward P/E ratio of 24.7x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on VET, with 3 Sell ratings and a price target of $10.74 (-8.0% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
VET analyst price targets range from $10.7426 to $10.7426, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $10.74 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.